9 top biopharma CEO-to-employee pay gaps
Despite weathering a difficult year, biopharma continues to see massive pay gaps between CEOs and their median employees, with top executives often earning hundreds of times more.
If you are not happy with the results below please do another search
Despite weathering a difficult year, biopharma continues to see massive pay gaps between CEOs and their median employees, with top executives often earning hundreds of times more.
The company announced today that it had agreed to buy privately held Human Immunology Biosciences for up to $1.8 billion, bulking up on rare disease medicines as its older multiple sclerosis drugs face tepid demand due to rising competition.
A large fire that broke out at a Novo Nordisk office building in Denmark on Wednesday has been brought under control, the local fire department said.
The experimental drug was in development to treat agitation and restlessness caused by symptoms of Alzheimer’s disease.
In her new role, Hutnik will lead Spectrum’s global platform of integrated services including enterprise- wide operations and growth planning across the company’s four strategic pillars: Scientific Communications, Advertising & Consulting, Clinical Trial Experience and Spectrum Science Europe.
Great progress has been made in the management of female infertility since the introduction of assisted reproductive technology, predominantly in vitro fertilization (IVF). However, despite the improvements made in the space, challenges associated with the treatment remain. The development of non-injectable fertility medications represents a significant unmet need, reports GlobalData.
Under the agreement, Dr. Reddy’s gets exclusive commercialization rights in the United States as well as semi-exclusive rights in Europe and United Kingdom, and Alvotech will be responsible for development and manufacture of the product.
Carlos Dortrait, senior vice president & general manager of U.S. Immunology & Neuroscience at Bristol Myers Squibb, explains the importance of empowering patients and giving them the confidence to speak with doctors so they can seek the treatment they need, in this case for treating plaque psoriasis. Actress, writer, and producer Mindy Kaling recently joined actor Ted Danson in the BMS “SO, Have You Found It?” campaign (with their video slated to be released soon), which aims to strengthen the voices of U.S. patients living with the condition. Danson has been living with plaque psoriasis for many years and Kaling, who does not have psoriasis, has the role of patient empowerment through self advocacy.
“In a rapidly changing healthcare landscape, new policies combined with significant cost pressures and evolving business models continue to impact drug access and potentially increase restrictions,” said Kim Wishnow-Per, President, MHMM. “We created these proprietary solutions following conversations with our client partners and listening to their specific needs. By designing these three offerings to help solve for their challenges, we are excited to bring new value to our clients and their customers.”
The British-Swedish company on Tuesday laid out an ambitious plan to boost growth in its existing oncology, biopharma and rare disease portfolios, as well as launch 20 new medicines before the end of the decade.